British drug company launches trial of potential Covid-19 treatment after encouraging early signs

  • 📰 The Independent
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 59%

United States News News

United States United States Latest News,United States United States Headlines

Calquence, a drug used to treat some forms of blood cancer, has shown promise in suppressing the exaggerated immune response that Covid-19 causes in some patients

Related video: Tom Hanks' wife Rita Wilson describes 'extreme' side effects of chloroquine during coronavirus recoveryhas confirmed plans to launch a global clinical trial testing one of its drugs in treating the extreme immune response triggered by Covid-19 in severely ill patients.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 80. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Drug company share holders right now

Reversing the cytokine storm?

Hoping it will work.

United States United States Latest News, United States United States Headlines